Lipids at the helm: a metabolic playbook for liver regeneration

Abstract

Ancient mythology alluded to the liver’s regenerative capabilities, a phenomenon now validated by scientific research: the organ can regenerate up to 75% of its mass following partial resection, provided sufficient tissue remains. This commentary synthesizes and contextualizes a recent review article that emphasizes lipid metabolism as a key component of liver regeneration. Effective regeneration depends on the viability of hepatocytes, contributions from supporting cells, metabolic adaptability, and appropriate management of infections and hemodynamics. The regenerative process unfolds in distinct phases: cytokine priming, cellular proliferation, and termination. In cases of acute injury, hepatocytes are primarily responsible for regeneration, whereas in chronic disease states, progenitor-like cells also contribute. Recovery is influenced by hormonal status, nutritional state, age, and signals from non-parenchymal cells, with zone 2 hepatocytes playing a pivotal role. Lipid metabolism is critical; moderate lipid accumulation supports regeneration, whereas excessive fat deposition hinders it. Lipophagy provides essential energy and mitigates toxicity, while endoplasmic reticulum (ER) stress must be properly regulated. Therapeutic strategies focus on optimizing β-oxidation, enhancing lipophagy, and managing ER stress, guided by lipid profiling and fat quantification. Personalized interventions tailored to phase-specific lipid metabolic needs may optimize liver regenerative outcomes.

Keywords

Gut-liver axis / endoplasmic reticulum stress / lipophagy / liver regeneration / non-recovering post-resection liver failure / metabolic flexibility / transient regenerative-associated steatosis

References

[1] Tiniakos DG,Kandilis A,Geller SA. Tityus: a forgotten myth of liver regeneration J Hepatol. 2010 53 357 61

[2] Kattner AA. Greek gods and the double-edged sword of liver regeneration Biomed J. 2021 44 515 20 PMC8640535

[3] Michalopoulos GK,Bhushan B. Liver regeneration: biological and pathological mechanisms and implications Nat Rev Gastroenterol Hepatol. 2021 18 40 55

[4] Kauffmann R,Fong Y. Post-hepatectomy liver failure Hepatobiliary Surg Nutr. 2014 3 238 46 PMC4207837

[5] Colle I,Verhelst X,Vanlander A.et al. Pathophysiology and management of post resection liver failure Acta Chir Belg. 2013 113 155 61

[6] Engelmann C. Peripheral fat mobilization and mitochondrial fat metabolism: Fueling the energy demands of liver regeneration J Hepatol. 2025 82 942 4

[7] Smith RL,Soeters MR,Wüst RCI,Houtkooper RH. Metabolic flexibility as an adaptation to energy resources and requirements in health and disease Endocr Rev. 2018 39 489 517 PMC6093334

[8] Wang X,Menezes CJ,Jia Y.et al. Metabolic inflexibility promotes mitochondrial health during liver regeneration Science. 2024 384 eadj4301 PMC11232486

[9] Lund A,Thomsen MT,Kirkegård J.et al. Role of steatosis in preventing post-hepatectomy liver failure after major resection: findings from an animal study J Clin Exp Hepatol. 2025 15 102453 PMC11652769

[10] Peltec A,Hotineanu A,Popescu I,Braşoveanu V. The impact of liver steatosis on the postoperative evolution after right lobe living-donor hepatectomy Med Pharm Rep. 2021 94 Suppl S43 50 PMC11188031

[11] Gilgenkrantz H,Collin de l’Hortet A. Understanding liver regeneration: from mechanisms to regenerative medicine Am J Pathol. 2018 188 1316 27

[12] Hora S,Wuestefeld T. Liver injury and regeneration: current understanding, new approaches, and future perspectives Cells. 2023 12 2129 PMC10486351

[13] Boyce S,Harrison D. A detailed methodology of partial hepatectomy in the mouse Lab Anim. 2008 37 529 32

[14] Zafarnia S,Mrugalla A,Rix A.et al. Non-invasive imaging and modeling of liver regeneration after partial hepatectomy Front Physiol. 2019 10 904 PMC6652107

[15] Xiaoguang Chen. A comprehensive review on liver regeneration termination: a non-neglectable phase Cytol. Genet. 2024 58 343 61

[16] Hirano T. IL-6 in inflammation, autoimmunity and cancer Int Immunol. 2021 33 127 48 PMC7799025

[17] Zhao Y,Ye W,Wang YD,Chen WD. HGF/c-met: a key promoter in liver regeneration Front Pharmacol. 2022 13 808855 PMC8968572

[18] Théret N,Feret J,Hodgkinson A,Boutillier P,Vignet P,Radulescu O. Integrative models for TGF-β signaling and extracellular matrix. In: Ricard-Blum S, Editors. Extracellular matrix omics. Cham: Springer International Publishing; 2020. pp. 209-25

[19] Sljukic A,Green Jenkinson J,Niksic A,Prior N,Huch M. Advances in liver and pancreas organoids: how far we have come and where we go next Nat Rev Gastroenterol Hepatol. 2026 23 44 64

[20] Malato Y,Naqvi S,Schürmann N.et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration J Clin Invest. 2011 121 4850 60 3226005

[21] Wei Y,Wang YG,Jia Y.et al. Liver homeostasis is maintained by midlobular zone 2 hepatocytes Science. 2021 371 PMC8496420

[22] He L,Pu W,Liu X.et al. Proliferation tracing reveals regional hepatocyte generation in liver homeostasis and repair Science 2021 371 eabc4346

[23] Duan L,Chang Y,Dai J.et al. Lipid metabolism orchestrates liver regeneration: an integrated metabolic network J Transl Med. 2025 23 1115 PMC12532872

[24] Yang Q,Nagano T,Shah Y,Cheung C,Ito S,Gonzalez FJ. The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha Toxicol Sci. 2008 101 132 9 PMC2197159

[25] Shizu R,Makida N,Sobe K.et al. Interaction with YAP underlies the species differences between humans and rodents in CAR-dependent hepatocyte proliferation Toxicol Sci. 2024 198 101 12

[26] Koch PS,Sandorski K,Heil J.et al. Imbalanced activation of Wnt-/β-catenin-signaling in liver endothelium alters normal sinusoidal differentiation Front Physiol. 2021 12 722394 PMC8511684

[27] Visekruna A,Luu M. The role of short-chain fatty acids and bile acids in intestinal and liver function, inflammation, and carcinogenesis Front Cell Dev Biol. 2021 9 703218 PMC8352571

[28] Bhalla S,Mcquillen B,Cay E,Reau N. Preoperative risk evaluation and optimization for patients with liver disease Gastroenterol Rep (Oxf). 2024 12 goae071 PMC11222301

[29] Peloso A,Tihy M,Moeckli B,Rubbia-Brandt L,Toso C. Clearing steatosis prior to liver surgery for colorectal metastasis: a narrative review and case illustration Nutrients. 2022 14 5340 PMC9785595

[30] Ahmed EA,El-Badry AM,Mocchegiani F.et al. Impact of graft steatosis on postoperative complications after liver transplantation Surg J (N Y). 2018 4 e188 96 PMC6193803

[31] de Meijer VE,Kalish BT,Puder M,Ijzermans JN. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection Br J Surg. 2010 97 1331 9

[32] Islam SMT,Palanisamy AP,Chedister GR,Schmidt MG,Lewin DNB,Chavin KD. Unsaturated or saturated dietary fat-mediated steatosis impairs hepatic regeneration following partial hepatectomy in mice PLoS ONE. 2023 18 e0284428 PMC10174548

[33] Fujita K,Nozaki Y,Wada K.et al. Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease Gut. 2008 57 1583 91

[34] Holländer S,von Heesen M,Gäbelein G.et al. Perioperative treatment with cilostazol reverses steatosis and improves liver regeneration after major hepatectomy in a steatotic rat model Sci Rep. 2025 15 2753 PMC11754906

[35] Luukkonen PK. Kinase inhibitor boosts liver regeneration and prevents liver failure J Hepatol. 2025 83 1455 6